Area of research
Toxicology · Pharmacology
Research interest
Research focused on Pharmacovigilance and Adverse effect, with related work in Amlodipine, Donepezil, Drug. Notable publications include 'Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database', 'Safety issues of Donepezil combined with Memantine in Alzheimer’s disease population: real-world pharmacovigilance', and 'The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer'.
Integrated bioinformatics and network search identify biomarkers and comorbid mechanisms of atrial fibrillation and ischemic stroke
Safety concerns associated with various types of statins: a disproportionality analysis of the FAERS database
Safety issues of Donepezil combined with Memantine in Alzheimer’s disease population: real-world pharmacovigilance
The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer
Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Letter to the Editor: Discussion on the suicide risk of CCB drugs: based on real-world drug safety surveillance